Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Risk of incident diabetes after initiation of 5α-reductase inhibitor plus α-blocker combination therapy: A nationwide cohort study with age-specific analyses.

AIMS To evaluate the association between initiation of 5α-reductase inhibitor plus α-blocker combination therapy (5ARI + AB) and incident diabetes compared with α-blocker (AB) monotherapy in men with benign prostatic hyperplasia. METHODS We conducted a nationwide active-comparator, new-user cohort study using the Kor...

Eonji Na, Bora Yeon, Bonggi Kim · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.